ZOLL Medical Corporation

297 articles with ZOLL Medical Corporation

• ZOLL Launches Next Generation MCT Solution, Shown to Improve Patient Management Decisions in Largest Ever MCT Trial

  3/21/2022

  ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the launch of the ZOLL Arrhythmia Management System.

• ZOLL Announces Closing of Acquisition of Itamar Medical

  12/16/2021

  ZOLL® Medical Corporation announced that it has successfully completed its previously announced acquisition of Itamar™ Medical Ltd., a medical device and digital health company that provides at-home testing for sleep apnea.

• ZOLL TherOx SuperSaturated Oxygen Therapy to Be Highlighted at TCT Scientific Symposium

  11/4/2021

  ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that its TherOx® SuperSaturated Oxygen Therapy will be highlighted at the upcoming Transcatheter Cardiovascular Therapeutics annual scientific meeting November 4-6 in Orlando, Florida.

• ZOLL Medical Corporation Signs Definitive Agreement to Acquire Itamar Medical

  9/13/2021

  ZOLL® Medical Corporation and Itamar™ Medical Ltd. announced that the two companies signed a definitive agreement under which ZOLL Medical will acquire all outstanding ordinary shares of Itamar Medical for a total value of approximately $538 million.

• ZOLL Medical Receives FDA IDE Approval for Initiation of ISO Shock (Incorporating Supersaturated Oxygen in Shock) Feasibility Study

  5/13/2021

  ZOLL Medical Receives FDA IDE Approval for Initiation of ISO Shock (Incorporating Supersaturated Oxygen in Shock) Feasibility Study Study Evaluates the Safety and Feasibility of TherOx Supersaturated Oxygen (SSO 2 ) Therapy in STEMI Patients presenting with Cardiogenic Shock

• Asahi Kasei Company ZOLL Medical Corporation Donates $10M to The ZOLL Foundation to Support the Next Generation of Innovative Researchers in Resuscitation and Acute Critical Care

  3/9/2021

  Asahi Kasei Corporation, a diversified Japanese multinational, announced that its U.S. subsidiary ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, donated $10M to the non-profit ZOLL Foundation in December 2020 to support research and educational activities for resuscitation and acute critical care.

• ZOLL Partners with U.S. Air Force Research Laboratory to Improve How Combat Medics Treat Their Patients

  11/17/2020

  ZOLL Medical Corporation and the U.S. Air Force Research Laboratory announced the signing of a patent license agreement to make it easier for the deployed medic to document vitals, help administer critical care, integrate patient data and identify exact location of casualties in austere combat environments.

• ZOLL’s Data Division Expands Into New Healthcare Markets

  11/12/2020

  ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that its software-as-a-service division is expanding its solutions portfolio into new markets to provide data interoperability and accounts receivable optimization to the healthcare industry.

• ZOLL AED 3 and Comprehensive Rescue System Honored for Ability to Improve Workplace Safety

  11/10/2020

  Two ZOLL Products Named 2020 New Products of the Year by Occupational Health & Safety Magazine

• ZOLL and CAIRE, Inc. Sign Exclusive Agreement for Outside-the-U.S. Distribution of Portable Oxygen Concentrator

  10/20/2020

  ZOLL ® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, and CAIRE, Inc., a leading oxygen supply manufacturer, today announced the signing of an exclusive distributor agreement. As part of this agreement, ZOLL has exclusive rights to distribute the SAROS® 4000 Portable Oxygen Concentrator in all markets outside the U.S. in combination with ZOLL’s EMV+® vent

• ZOLL Introduces New AED With Enhanced Real CPR Help, Integrated Child Rescue, and Wireless Connectivity

  6/2/2020

  ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today that the ZOLL AED 3® defibrillator received premarket approval (PMA) by the FDA for use by lay rescuers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200602005565/en/ ZOLL AED 3 (Photo: Business Wire) “ZOLL

• ZOLL Announces Return of Department of Health and Human Services Funds Distribution

  5/11/2020

  ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, announced the return of funds it received from the Department of Health and Human Services (HHS) as part of the CARES Act Provider Relief Fund. The CARES Act Provider Relief Fund allocated $50 billion for distribution to Medicare facilities and providers impacted by COVID-19. HHS provided automa

• ZOLL TherOx Receives CE Mark Approval for SuperSaturated Oxygen Therapy

  5/4/2020

  ZOLL ® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today it has received CE Mark approval to market and distribute its SuperSaturated Oxygen (SSO 2 ) Therapy System in Europe. SSO 2 Therapy provides interventional cardiologists with the first and only clinically proven treatment beyond percutaneous coronary intervention (PCI) to signifi

• 

  In Other (Biopharma) News: Non-Coronavirus Stories this Week

  3/31/2020

  The following is a roundup of some of this week's non-coronavirus biopharma news.

• FDA Approves Next-Generation ZOLL® TherOx System for Widowmaker Heart Attack Patients

  3/30/2020

  March 30, 2020 13:23 UTC FDA Approves Next-Generation ZOLL ® TherOx System for Widowmaker Heart Attack Patients First and Only Treatment to Reduce Heart Muscle Damage Following Angioplasty and Stenting CHELMSFORD, Mass.--( BUSINESS WIRE )-- ZOLL ® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, announced today it has received U.S. Food and Drug Administration (FDA) approval of the second-generation Ther

• ZOLL Executing a Plan to Build 10,000 Ventilators/Month in Response to COVID-19 Pandemic

  3/24/2020

  ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, is taking aggressive steps to increase manufacturing capacity to 10,000 ventilators per month in response to the COVID-19 pandemic.

• ZOLL Medical Completes Acquisition of Cardiac Science

  8/27/2019

  ZOLL Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today confirmed that it has completed the previously announced acquisition of Cardiac Science® Corporation, a leading provider of automated external defibrillators (AEDs), related services, and accessories.

• ZOLL Acquires Mobilize RRS LLC.

  7/22/2019

  Offers Interactive First Aid Systems to Help Bystanders Save Lives

• Zoll Medical Corporation Acquires TherOx, Inc.

  6/18/2019

  Offers New Therapy for Treating Heart Patients in the Cath Lab

• ZOLL Signs Definitive Agreement to Purchase Cardiac Science

  6/11/2019

  Greater Range of Solutions for Sudden Cardiac Arrest Victims and Expansion of National AED Registry Anticipated